Tobi, an inhaled version of tobramycin

    The FDA just approved Tobi, an INHALED version of control lung infections in patients with cystic fibrosis.

    These patients often use INJECTABLE tobramycin solution and put it in a nebulizer.

    But Tobi is formulated specifically for doesn't take as long to nebulize and it may be better tolerated.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote